The Early Days: The Postkidney Transplant Recipients' COVID-19 Journey

Clin J Am Soc Nephrol. 2020 Sep 7;15(9):1221-1223. doi: 10.2215/CJN.08780620. Epub 2020 Jul 29.

Authors

Glenda V Roberts^{1

2

3}, Patrick O Gee^{3

4}

Affiliations

¹ Kidney Research Institute, University of Washington, Seattle, Washington.
² Center for Dialysis Innovation, University of Washington, Seattle, Washington.
³ Kidney Health Initiative's Patient and Family Partnership Council, Washington, DC.
⁴ iAdvocate, Inc., North Chesterfield, Virginia.

No abstract available

Keywords: COVID-19; Postkidney transplant recipient.

Publication types

Editorial

MeSH terms

Adaptation, Psychological
Betacoronavirus / immunology
Betacoronavirus / pathogenicity*
COVID-19
Coronavirus Infections / immunology
Coronavirus Infections / prevention & control*
Coronavirus Infections / transmission
Coronavirus Infections / virology
Cost of Illness
Female
Health Knowledge, Attitudes, Practice*
Host Microbial Interactions
Humans
Immunocompromised Host*
Immunosuppressive Agents / administration & dosage
Immunosuppressive Agents / adverse effects*
Kidney Transplantation / adverse effects*
Male
Opportunistic Infections / immunology
Opportunistic Infections / prevention & control*
Opportunistic Infections / transmission
Opportunistic Infections / virology
Pandemics / prevention & control*
Patient Education as Topic
Patient Safety
Pneumonia, Viral / immunology
Pneumonia, Viral / prevention & control*
Pneumonia, Viral / transmission
Pneumonia, Viral / virology
Risk Assessment
Risk Factors
SARS-CoV-2
Self Care*

Substances

Immunosuppressive Agents